Transplant Statistics: Annual Report

	Year of Transplant
	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000
Total # of Post-Tx Malignancies	24	43	46	44	46	55	47	40	30	16
Malignancies by Type	14	18	20	18	21	26	17	12	10	4
Squamous/Basal Cell Carcinoma
Melanoma	-	1	1	1	-	2	2	1	-	-
Kaposi Sarcoma	-	-	-	-	-	-	-	-	5	1
Central Nervous System	1	-	-	-	-	4	-	-	-	-
Genito-Urinary (1)	-	3	3	3	2	1	3	6	2	1
Gastro-Intestinal (2)	3	4	3	9	8	11	7	8	4	2
Primary Hepatic Tumor	1	1	-	1	1	1	4	5	2	2
Metastatic Hepatic Tumor	-	1	2	-	1	1	2	2	2	2
Larynx/Bronchi/Lung	-	3	9	6	5	7	2	4	-	3
Breast/Thyroid/Adrenal	1	4	4	6	5	1	3	1	1	-
Leukemia	-	-	-	-	2	-	-	-	-	-
Other	4	8	4	-	1	1	5	1	2	-
Unknown	-	-	-	-	-	-	2	-	2	1
Malignancies by Type(%)	58.3%	41.9%	43.5%	40.9%	45.7%	47.3%	36.2%	30.0%	33.3%	25.0%
Squamous/Basal Cell Carcinoma
Melanoma	-	2.3%	2.2%	2.3%	-	3.6%	4.3%	2.5%	-	-
Kaposi Sarcoma	-	-	-	-	-	-	-	-	16.7%	6.3%
Central Nervous System	4.2%	-	-	-	-	7.3%	-	-	-	-
Genito-Urinary (1)	-	7.0%	6.5%	6.8%	4.3%	1.8%	6.4%	15.0%	6.7%	6.3%
Gastro-Intestinal (2)	12.5%	9.3%	6.5%	20.5%	17.4%	20.0%	14.9%	20.0%	13.3%	12.5%
Primary Hepatic Tumor	4.2%	2.3%	-	2.3%	2.2%	1.8%	8.5%	12.5%	6.7%	12.5%
Metastatic Hepatic Tumor	-	2.3%	4.3%	-	2.2%	1.8%	4.3%	5.0%	6.7%	12.5%
Larynx/Bronchi/Lung	-	7.0%	19.6%	13.6%	10.9%	12.7%	4.3%	10.0%	-	18.8%
Breast/Thyroid/Adrenal	4.2%	9.3%	8.7%	13.6%	10.9%	1.8%	6.4%	2.5%	3.3%	-
Leukemia	-	-	-	-	4.3%	-	-	-	-	-
Other	16.7%	18.6%	8.7%	-	2.2%	1.8%	10.6%	2.5%	6.7%	-
Unknown	-	-	-	-	-	-	4.3%	-	6.7%	6.3%
Total # of Patients	18	28	37	34	36	43	39	37	22	15

Source: OPTN/SRTR Data as of August 1, 2001.

(-) = None in category.

(1) Genito-Urinary: kidney, bladder, uterine cervix, uterine body, ovarian, vulva, testicular, prostate.

(2) Gastro-Intestinal: tongue, throat, esophagus, stomach, small intestine, colo-rectal, liver and biliary tract, pancreas.

(3) Sarcoma: fibrosarcoma, osteosarcoma, etc.

Patients may have more than one posttransplant malignancy reported due to multiple follow-up forms.